Skip to main content
Premium Trial:

Request an Annual Quote

AxCell, University of Muenster To Study Neurodegenerative Proteins

NEW YORK, April 24-Cytogen subsidiary AxCell Biosciences said today that it will partner with researchers at the University of Muenster to research proteins involved in neurodegenerative disease.

 

AxCell will provide data from its signal transduction database, and the research will seek to understand the signaling pathway of a neuronal protein thought to be involved in degenerative disorders and Alzheimer's disease.

 

Under the deal, discoveries will be the joint property of the university and the company. AxCell retains an option to negotiate an exclusive, worldwide, royalty-bearing license from the university for any discoveries.

 

AxCell did not name the gene that would be the focus of this research, but said that the work would be led by Joachim Kremerskothen and Angelika Barnelow, who study neuronal proteins produced by dendritic-localized mRNAs. Normal transcription of dendritic mRNA, said the company, is essential for learning and memory.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.